SPY450.64+3.45 0.77%
DIA354.46+1.96 0.56%
IXIC15,129.09+107.28 0.71%

UBS Adjusts Price Target on HCA Healthcare to $312 From $280, Maintains Buy Rating

MT Newswires · 09/24/2021 07:35

Please log in to view news